Indraprastha Medical Corporation Limited (INDRAMEDCO.NS)
INR 500.05
(-0.28%)
INR 500.05
(-0.28%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 12.44 Billion | 10.98 Billion | 8.62 Billion | 5.96 Billion | 7.96 Billion | 7.6 Billion |
| Cost of Revenue | 7.9 Billion | 4.74 Billion | 3.83 Billion | 2.48 Billion | 3.52 Billion | 3.42 Billion |
| Gross Profit | 4.54 Billion | 6.24 Billion | 4.78 Billion | 3.47 Billion | 4.44 Billion | 4.17 Billion |
| Operating Expenses | 1.57 Billion | 5.13 Billion | 3.93 Billion | 3.39 Billion | 3.89 Billion | 3.65 Billion |
| Selling, General and Administrative Expenses | 1.15 Billion | 986.7 Million | 602.1 Million | 320.87 Million | 569.19 Million | 499.73 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.97 Billion | 100.3 Million | 31.2 Million | 6.78 Million | 3.32 Billion | 3.15 Billion |
| Cost and Expenses | 10.89 Billion | 9.87 Billion | 7.77 Billion | 5.88 Billion | 7.42 Billion | 7.07 Billion |
| Operating Income | 1.55 Billion | 1.12 Billion | 851.3 Million | 76.6 Million | 544.36 Million | 524.49 Million |
| Interest Expense | 40.6 Million | 42.8 Million | 100 Thousand | 40 Thousand | 11.31 Million | 30.01 Million |
| Income Tax Expense | 421.5 Million | 310.3 Million | 204.5 Million | 19.6 Million | 45.68 Million | 162.08 Million |
| Earnings before Tax | 1.66 Billion | 1.17 Billion | 790.7 Million | 42.89 Million | 481.92 Million | 446.21 Million |
| Net Income | 1.23 Billion | 861.5 Million | 586.2 Million | 23.3 Million | 436.24 Million | 284.13 Million |
| Earnings Per Share Basic | 13.52 | 9.40 | 6.39 | 0.25 | 4.76 | 3.10 |
| Earnings Per Share Diluted | 13.52 | 9.40 | 6.39 | 0.25 | 4.76 | 3.10 |
| Weighted Average Shares Outstanding | 91.68 Million | 91.67 Million | 91.67 Million | 91.67 Million | 91.67 Million | 91.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.67 Million | 91.67 Million | 91.67 Million | 91.67 Million | 91.67 Million | 91.67 Million |
| Gross Margin | 0.36 | 0.57 | 0.56 | 0.58 | 0.56 | 0.55 |
| EBIT Margin | 0.17 | 0.15 | 0.14 | 0.06 | 0.10 | 0.10 |
| Profit Margin | 0.10 | 0.08 | 0.07 | 0.00 | 0.05 | 0.04 |
| EBITDA | 2.1 Billion | 1.6 Billion | 1.17 Billion | 409.48 Million | 870.78 Million | 812.46 Million |
| Earnings Before Tax Margin | 0.13 | 0.10 | 0.10 | 0.01 | 0.07 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 3.49 Billion | 3.47 Billion | 3.14 Billion | 12.44 Billion | 3.06 Billion | 3.17 Billion |
| Cost of Revenue | 2.3 Billion | 2.27 Billion | 2.1 Billion | 8.3 Billion | 1.27 Billion | 1.34 Billion |
| Gross Profit | 1.19 Billion | 1.2 Billion | 1.04 Billion | 4.14 Billion | 1.78 Billion | 1.82 Billion |
| Operating Expenses | 671.8 Million | 645.5 Million | 658.4 Million | 2.6 Billion | 1.41 Billion | 1.42 Billion |
| Selling, General and Administrative Expenses | 671.8 Million | 645.5 Million | 658.4 Million | - | 651.5 Million | 649 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 51.2 Million | 48.9 Million | 168.9 Million | 42.7 Million | 41.7 Million |
| Cost and Expenses | 2.97 Billion | 2.91 Billion | 2.76 Billion | 10.91 Billion | 2.69 Billion | 2.76 Billion |
| Operating Income | 524.7 Million | 560.8 Million | 382.3 Million | 1.53 Billion | 415.4 Million | 445 Million |
| Interest Expense | 15.9 Million | 16.1 Million | 15.6 Million | 40.6 Million | 8.7 Million | 8.5 Million |
| Income Tax Expense | 145.3 Million | 148.2 Million | 103.9 Million | 421.5 Million | 112.3 Million | 117.4 Million |
| Earnings before Tax | 569.3 Million | 595.9 Million | 415.6 Million | 1.66 Billion | 406.7 Million | 436.5 Million |
| Net Income | 424 Million | 447.7 Million | 311.7 Million | 1.23 Billion | 294.4 Million | 328.5 Million |
| Earnings Per Share Basic | 4.63 | 4.88 | 3.40 | - | 3.21 | 3.58 |
| Earnings Per Share Diluted | 4.63 | 4.88 | 3.40 | - | 3.21 | 3.58 |
| Weighted Average Shares Outstanding | 91.67 Million | 91.67 Million | 91.67 Million | 91.68 Million | 91.67 Million | 91.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.67 Million | 91.67 Million | 91.67 Million | 91.68 Million | 91.67 Million | 91.67 Million |
| Gross Margin | 0.34 | 0.35 | 0.33 | 0.33 | 0.58 | 0.58 |
| EBIT Margin | 0.20 | 0.19 | 0.15 | - | 0.17 | 0.17 |
| Profit Margin | 0.12 | 0.13 | 0.10 | 0.10 | 0.10 | 0.10 |
| EBITDA | 696.9 Million | 671.2 Million | 484.4 Million | - | 515.7 Million | 545.3 Million |
| Earnings Before Tax Margin | 0.15 | 0.16 | 0.12 | 0.12 | 0.14 | 0.14 |
CBE
NKRKF
KWE
GAEL
ILU
DNZOF